|
Market Closed -
Australian S.E.
10:10:11 03/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.260 AUD | -1.20% |
|
-21.48% | -33.71% |
| 08-28 | Morgans Financial Downgrades Clinuvel Pharmaceuticals to Hold from Speculative Buy; Price Target is AU$10 | MT |
| 08-27 | Clinuvel Pharmaceuticals Limited, 2026 Earnings Call, Aug 27, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 302M | |||||
| 85.08B | |||||
| 60.21B | - | ||||
| 59.71B | |||||
| 51.1B | |||||
| 48.73B |
Select your edition
All financial news and data tailored to specific country editions
